146 related articles for article (PubMed ID: 37503578)
21. On non-inferiority analysis based on delta-method confidence intervals.
Rothmann MD; Tsou HH
J Biopharm Stat; 2003 Aug; 13(3):565-83. PubMed ID: 12921402
[TBL] [Abstract][Full Text] [Related]
22. Superiority and non-inferiority: two sides of the same coin?
Dunn DT; Copas AJ; Brocklehurst P
Trials; 2018 Sep; 19(1):499. PubMed ID: 30223881
[TBL] [Abstract][Full Text] [Related]
23. A note on the conservativeness of the confidence interval approach for the selection of non-inferiority margin in the two-arm active-control trial.
Sankoh AJ
Stat Med; 2008 Aug; 27(19):3732-42. PubMed ID: 18407575
[TBL] [Abstract][Full Text] [Related]
24. Bayesian approach for assessing non-inferiority in a three-arm trial with pre-specified margin.
Ghosh S; Ghosh S; Tiwari RC
Stat Med; 2016 Feb; 35(5):695-708. PubMed ID: 26434554
[TBL] [Abstract][Full Text] [Related]
25. Blinded sample size re-estimation in three-arm trials with 'gold standard' design.
Mütze T; Friede T
Stat Med; 2017 Oct; 36(23):3636-3653. PubMed ID: 28608469
[TBL] [Abstract][Full Text] [Related]
26. Planning and analysis of three-arm non-inferiority trials with binary endpoints.
Kieser M; Friede T
Stat Med; 2007 Jan; 26(2):253-73. PubMed ID: 16685703
[TBL] [Abstract][Full Text] [Related]
27. New approaches for testing non-inferiority for three-arm trials with Poisson distributed outcomes.
Ghosh S; Paul E; Chowdhury S; Tiwari RC
Biostatistics; 2022 Jan; 23(1):136-156. PubMed ID: 32385495
[TBL] [Abstract][Full Text] [Related]
28. A regulatory perspective on choice of margin and statistical inference issue in non-inferiority trials.
Hung HM; Wang SJ; O'Neill R
Biom J; 2005 Feb; 47(1):28-36; discussion 99-107. PubMed ID: 16395994
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous confidence intervals for ratios with application to the gold standard design with more than one experimental treatment.
Schmidt S; Brannath W
Stat Med; 2019 Dec; 38(28):5350-5360. PubMed ID: 31621938
[TBL] [Abstract][Full Text] [Related]
30. Group sequential designs for three-arm 'gold standard' non-inferiority trials with fixed margin.
Schlömer P; Brannath W
Stat Med; 2013 Dec; 32(28):4875-89. PubMed ID: 23970488
[TBL] [Abstract][Full Text] [Related]
31. Recommendations for designing and analysing multi-arm non-inferiority trials: a review of methodology and current practice.
Emmerson J; Todd S; Brown JM
Trials; 2021 Jun; 22(1):417. PubMed ID: 34174937
[TBL] [Abstract][Full Text] [Related]
32. Study duration for three-arm non-inferiority survival trials designed for accrual by cohorts.
Wu Y; Li Y; Hou Y; Li K; Zhou X
Stat Methods Med Res; 2018 Feb; 27(2):507-520. PubMed ID: 26994213
[TBL] [Abstract][Full Text] [Related]
33. Non-inferiority test for a continuous variable with a flexible margin in an active controlled trial: an application to the "Stratall ANRS 12110 / ESTHER" trial.
Sandie AB; Molinari N; Wanjoya A; Kouanfack C; Laurent C; Tchatchueng-Mbougua JB
Trials; 2022 Mar; 23(1):202. PubMed ID: 35248123
[TBL] [Abstract][Full Text] [Related]
34. Non-inferiority versus superiority drug claims: the (not so) subtle distinction.
Ganju J; Rom D
Trials; 2017 Jun; 18(1):278. PubMed ID: 28619049
[TBL] [Abstract][Full Text] [Related]
35. A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer.
Sampayo-Cordero M; Miguel-Huguet B; Malfettone A; López-Miranda E; Gion M; Abad E; Alcalá-López D; Pérez-Escuredo J; Pérez-García JM; Llombart-Cussac A; Cortés J
Front Oncol; 2023; 13():1048242. PubMed ID: 37496662
[TBL] [Abstract][Full Text] [Related]
36. Design and analysis of three-arm trials with negative binomially distributed endpoints.
Mütze T; Munk A; Friede T
Stat Med; 2016 Feb; 35(4):505-21. PubMed ID: 26388314
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous confidence intervals on multivariate non-inferiority.
Hasler M; Hothorn LA
Stat Med; 2013 May; 32(10):1720-9. PubMed ID: 22996204
[TBL] [Abstract][Full Text] [Related]
38. Non-inferiority trials in cardiology: what clinicians need to know.
Leung JT; Barnes SL; Lo ST; Leung DY
Heart; 2020 Jan; 106(2):99-104. PubMed ID: 31672779
[TBL] [Abstract][Full Text] [Related]
39. Non-inferiority tests for anti-infective drugs using control group quantiles.
Fay MP; Follmann DA
Clin Trials; 2016 Dec; 13(6):632-640. PubMed ID: 27430709
[TBL] [Abstract][Full Text] [Related]
40. Non-inferiority designs comparing placebo to a proven therapy for childhood pneumonia in low-resource settings.
May S; Brown SP; Schmicker RH; Emerson SS; Nkwopara E; Ginsburg AS
Clin Trials; 2020 Apr; 17(2):129-137. PubMed ID: 31814441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
